Cencora Inc. (COR)vsCosmos Health Inc. (COSM)
COR
Cencora Inc.
$309.87
-0.95%
HEALTHCARE · Cap: $59.59B
COSM
Cosmos Health Inc.
$0.35
-7.50%
HEALTHCARE · Cap: $40.92M
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 451250% more annual revenue ($332.77B vs $73.73M). COR leads profitability with a 0.8% profit margin vs -33.1%. COR earns a higher WallStSmart Score of 62/100 (C+).
COR
Buy62
out of 100
Grade: C+
COSM
Hold36
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-63.9%
Fair Value
$189.03
Current Price
$309.87
$120.84 premium
Intrinsic value data unavailable for COSM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 86 in profit
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Generating 2.4B in free cash flow
Reasonable price relative to book value
Revenue surging 28.8% year-over-year
Areas to Watch
Trading at 19.4x book value
0.8% margin — thin
Operating margin of 1.4%
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -106.6% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, Altman Z-Score, Market Cap. PEG of 0.66 suggests the stock is reasonably priced for its growth.
Bull Case : COSM
The strongest argument for COSM centers on Price/Book, Revenue Growth. Revenue growth of 28.8% demonstrates continued momentum.
Bear Case : COR
The primary concerns for COR are Price/Book, Profit Margin, Operating Margin. Debt-to-equity of 3.84 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.
Bear Case : COSM
The primary concerns for COSM are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
COR profiles as a value stock while COSM is a growth play — different risk/reward profiles.
COSM carries more volatility with a beta of 4.17 — expect wider price swings.
COSM is growing revenue faster at 28.8% — sustainability is the question.
COR generates stronger free cash flow (2.4B), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 36/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Cosmos Health Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?